News

US President Donald Trump on May 23 threatened to impose a 50 percent tariff on all imports from the European Union.
U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...
Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...
U.S. dependency on China for critical goods like rare earths and pharmaceuticals poses risks. Trump's strategies aim to ...
The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to impose ... in place escalating tariffs on imports from China, raising them to 145 percent ...
Trump and his aides have repeatedly shifted their stance on tariffs in the weeks since the president’s “Liberation Day” announcement.